Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT06373991
What this trial is testing

Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
EdiGene Inc. 12
Large-scale testing (Phase 3)Looking for participantsNCT07355218
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Who this might be right for
Systematic Lupus ErythematosusCutaneous Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 202
Not applicableStudy completedNCT06234852
What this trial is testing

Gradual Withdrawal of Low-dose Glucocorticoid in Clinically Quiescent Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus, SLE
Phramongkutklao College of Medicine and Hospital 20
Large-scale testing (Phase 3)Looking for participantsNCT06617325
What this trial is testing

Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
UCB Biopharma SRL 450
Not applicableActive Not RecruitingNCT06659068
What this trial is testing

Efficacy of Seluang Fish Oil (Rasbora Argyrotaenia) and Synbiotics Supplementation on CD4+CD25+ Foxp3+ T-regulator Cells, IL17/IL-10 Ratio, and Disease Activity in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Universitas Sriwijaya 40
Large-scale testing (Phase 3)Looking for participantsNCT07751848
What this trial is testing

Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 417
Not applicableUnknownNCT02403115
What this trial is testing

Prediction of Outcome of Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Istituto Giannina Gaslini 800
Not applicableStudy completedNCT01157468
What this trial is testing

Catalytic Antibodies and Lupus in Martinique

Who this might be right for
Systemic Lupus Erythematosus
University Hospital Center of Martinique 200
Large-scale testing (Phase 3)WithdrawnNCT05063513
What this trial is testing

Autologous Stem Cell Transplantation: International Lupus Trial

Who this might be right for
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
European Society for Blood and Marrow Transplantation
Testing effectiveness (Phase 2)Study completedNCT00094380
What this trial is testing

Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Ended earlyNCT00089804
What this trial is testing

Study of LJP 394 in Lupus Patients With History of Renal Disease

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
La Jolla Pharmaceutical Company 943
Not applicableNot Yet RecruitingNCT07545408
What this trial is testing

Subclinical Atherosclerosis in Juvenile Systemic Lupus Erythematosus

Who this might be right for
Atherosclerosis
Assiut University 70
Not applicableStudy completedNCT06485674
What this trial is testing

Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus

Who this might be right for
Long-Term Organ Damage in Adult Patients With Active Systemic Lupus Erythematosus
AstraZeneca 561
Early research (Phase 1)Active Not RecruitingNCT05869955
What this trial is testing

CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathySystemic Sclerosis+1 more
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 270
Testing effectiveness (Phase 2)Study completedNCT05856448
What this trial is testing

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Lakefront Biotherapeutics NV 186
Early research (Phase 1)Looking for participantsNCT06349343
What this trial is testing

CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 20
Early research (Phase 1)Study completedNCT03174587
What this trial is testing

Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Corestemchemon, Inc. 7
Not applicableStudy completedNCT00786409
What this trial is testing

Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women

Who this might be right for
Systemic Lupus Erythematosus
University of Chicago 27
Post-approval studies (Phase 4)Active Not RecruitingNCT06411249
What this trial is testing

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 303
Early research (Phase 1)Study completedNCT00547014
What this trial is testing

First Safety Study in Humans of a Single Dose of CPG 52364

Who this might be right for
Healthy Volunteers
Pfizer 61
Next Page